You searched for side effects - Page 86 of 311 - Medivizor
Navigation Menu

Cardiac function of survivors of childhood acute lymphoblastic leukemia treated with anthracyclines

Cardiac function of survivors of childhood acute lymphoblastic leukemia treated with anthracyclines

Posted by on Aug 9, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the heart function of acute lymphoblastic leukemia survivors who had been treated with anthracyclines. This study concluded that these patients had decreased heart function long after treatment. Some background Anthracyclines are a type of chemotherapy drug. Examples are daunorubicin...

Read More

Evaluating long-term bowel function after low-anterior surgery for rectal cancer

Evaluating long-term bowel function after low-anterior surgery for rectal cancer

Posted by on Aug 9, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the long-term side effects of low anterior surgery for rectal cancer. Researchers suggested that radiation before surgery is associated with poorer bowel function after surgery. Some background Rectal cancer is a frequent and serious disease. In the US there are 43,340 new cases of rectal cancer every...

Read More

Desmopressin improves the outcomes of elderly patients with nocturnal polyuria

Desmopressin improves the outcomes of elderly patients with nocturnal polyuria

Posted by on Aug 9, 2020 in Nocturia | 0 comments

In a nutshell This study investigated the short-term effectiveness and safety of desmopressin in elderly patients with nocturia (NOC; waking up at night more than one time to urinate). Researchers suggested that this drug might be a good and safe option for the treatment of these patients. Some background NOC can be caused by a variety of factors....

Read More

Are low-dose glucocorticoids safe and effective in combination with methotrexate and hydroxychloroquine in early rheumatoid arthritis?

Are low-dose glucocorticoids safe and effective in combination with methotrexate and hydroxychloroquine in early rheumatoid arthritis?

Posted by on Aug 9, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the use of low dose (LD) glucocorticoids (GC) combined with methotrexate (MTX; Otrexup) and hydroxychloroquine (HCQ; Plaquenil).in early rheumatoid arthritis (RA). They found that LD-GCs improved disease activity (DA) combined with MTX and HCQ in these patients. Some background...

Read More

Deep brain stimulation improves the long-term outcomes of patients with early Parkinson’s disease

Deep brain stimulation improves the long-term outcomes of patients with early Parkinson’s disease

Posted by on Aug 9, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the long-term effectiveness of deep brain stimulation (DBS) in early-stage Parkinson's disease (PD). Researchers suggested that DBS reduces the need for PD medication while improving long-term outcomes. Some background PD is a chronic disorder that affects brain cells. These cells lose their ability to control...

Read More

Can high-risk prostate cancer be treated with high-dose-rate brachytherapy, external beam radiotherapy plus long-term androgen deprivation therapy?

Can high-risk prostate cancer be treated with high-dose-rate brachytherapy, external beam radiotherapy plus long-term androgen deprivation therapy?

Posted by on Aug 9, 2020 in Prostate cancer | 0 comments

In a nutshell This study looked at whether the use of high-dose (HD) brachytherapy (BT) and hypofractionated external beam radiotherapy (EBRT) plus androgen-deprivation therapy (ADT) as a means of treatment for very high-risk prostate cancer (PCa). The study found that this treatment had significant benefits for patients with high-risk...

Read More

Combining daratumumab with carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma

Combining daratumumab with carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma

Posted by on Jul 31, 2020 in Multiple Myeloma | 0 comments

In a nutshell The study evaluated outcomes of the combination of carfilzomib (Kyprolis; K), dexamethasone (Decadron; d), and daratumumab (Darzalex; D) in patients with relapsed or refractory (r/r) multiple myeloma (MM). The authors found that KdD was safe and effective to improve progression-free survival (PFS) in such patients compared to...

Read More

Does a dual-trigger treatment improve IVF outcomes in older patients with diminished ovarian reserve?

Does a dual-trigger treatment improve IVF outcomes in older patients with diminished ovarian reserve?

Posted by on Jul 30, 2020 in Infertility | 0 comments

In a nutshell This study investigated if a dual-trigger treatment (DTT) improves pregnancy outcomes in older women with diminished ovarian reserve (DOR).  They found that DTT improved in vitro fertilization (IVF) outcomes in these women. Some background In vitro fertilization (IVF) is an assisted reproductive technique (ART). The first step of...

Read More